Refractory Thyroid Gland Follicular Carcinoma
generalA thyroid gland follicular carcinoma that is resistant to treatment.
15
Centers
0
Active Trials
—
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Refractory Thyroid Gland Oncocytic Carcinoma | — |
Top Centers for Refractory Thyroid Gland Follicular Carcinoma(15)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive | 53.3 |
| 2 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | 53.3 |
| 3 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | 53.3 |
| 4 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 53.3 |
| 5 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 53.3 |
| 6 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 53.3 |
| 7 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive | 53.3 |
| 8 | NCI Comprehensive | 53.3 |
| 9 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive | 53.3 |
| 10 | University of Illinois Cancer CenterChicago, IL | 53.3 |
| 11 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 53.3 |
| 12 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 53.3 |
| 13 | Cancer Center at IllinoisUrbana, IL | 53.3 |
| 14 | Penn State Cancer InstituteHershey, PA | 53.3 |
| 15 | Princess Margaret Cancer CentreToronto, ON | 53.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →